$EQ ripping +35% AH 🚀 🔹 Equillium catching major after-hours momentum as biotech bulls step in 📈 🔹 Clinical-stage biotech focused on severe autoimmune & inf

$EQ ripping +35% AH 🚀 🔹 Equillium catching major after-hours momentum as biotech bulls step in 📈 🔹 Clinical-stage biotech focused on severe autoimmune & inflammatory diseases 🧬 🔹 Recent buzz includes shareholder approval for reverse split/capital changes + Jefferies Healthcare Conference parti…